跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
VAXZEVRIA SUSPENSION INYECTABLE - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
VAXZEVRIA SUSPENSION INYECTABLE
Approved
STANDARD
VAXZEVRIA SUSPENSION INYECTABLE
Astrazeneca Ab
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Jan 31, 2021
Approval ID
d7bf0f80c66da517
Company
Astrazeneca Ab
Type
Standard
Approval Details
Approval Id
d7bf0f80c66da517
Drug Cima Aemps Name
VAXZEVRIA SUSPENSION INYECTABLE
Register Number
1211529001
Holder Company Name
Astrazeneca Ab
Marketing Company Name
Astrazeneca Farmaceutica Spain S.A.
Holder Company Detail Path
/organization/astrazeneca-ab
Authorization Date
2021-01-31
Dosage Form
SUSPENSIÓN INYECTABLE
Dose
no menos de 2,5 × 10e8 Unidades Infecciosas/0,5 ml
Route Of Administration
VÍA INTRAMUSCULAR
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
No
Company Name
Astrazeneca Ab
Company Detail Path
/organization/astrazeneca-ab
Company Information
Pharmaceutical Company Name
ASTRAZENECA AB
Country Name
Spain
City Name
madrid,madrid,country_es
Address
CALLE RAIMUNDO FERNANDEZ VILLAVERDE 63
Website
http://www.astrazeneca.se
Active Ingredients
VACUNA RECOMBINANTE (CHADOX1-S) FRENTE A COVID-19 (ASTRAZENECA)
5 x 10e8 unidades infecciosas (Inf.U)
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Jan 31, 2021
Approval ID
d7bf0f80c66da517
Type
Standard
Back to CIMA-AEMPS Approvals